StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Mackie

<< Previous

Bullboard Posts

Next >>

Comment by frewil11on Feb 11, 2021 9:48am

133 Views

Post# 32536411

RE:RE:RE:Mackie

People wonder why this is not taking off with the roll out of Aristotle weeks away , the market does not forget that Colonsentry was a great product but the company failed to monetize it , what a shame because it could have saves a lot of lives , this by no means is a slam dunk , I hope it all works out because I want to get everybody close to me to get a test.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing